Ewing Sarcoma Breakpoint Region 1-Friend Leukemia Integration 1 Transcription factor (EWSR1-FLI1)
Showing 51 - 75 of >10,000
Advanced Soft-tissue Sarcoma Trial in Shenzhen (NY-ESO-1 TCR-T)
Recruiting
- Advanced Soft-tissue Sarcoma
- NY-ESO-1 TCR-T
-
Shenzhen, Guangdong, ChinaLi Yu
Nov 17, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CPI 613
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
May 10, 2023
Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in
Suspended
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)
Recruiting
- Advanced Sarcoma
- +2 more
- YH001
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Dec 5, 2022
Solid Tumors and Hematologic Malignancy Trial in Belgium, Netherlands, United States (INCB059872, all-trans retinoic acid
Terminated
- Solid Tumors and Hematologic Malignancy
- INCB059872
- +3 more
-
Birmingham, Alabama
- +14 more
Jun 29, 2022
Synovial Sarcoma, Myxoid Liposarcoma Trial in Worldwide (afamitresgene autoleucel (previously ADP-A2M4))
Recruiting
- Synovial Sarcoma
- Myxoid Liposarcoma
- afamitresgene autoleucel (previously ADP-A2M4)
-
Duarte, California
- +26 more
Dec 7, 2022
MiT Family Translocation Renal Cell Carcinomas (IMCOR)
Not yet recruiting
- Renal Carcinoma
- Data collection
-
Bordeaux, France
- +3 more
Jul 8, 2022
Acute Myeloid Leukemia Trial in Antalya
Recruiting
- Acute Myeloid Leukemia
-
Antalya, TurkeyAntalya Training and Research Hospital
Jul 29, 2023
SOX2 & PDL1 Expression on Urinary Bladder Carcinoma
Not yet recruiting
- Urinary Bladder Neoplasm
- (no location specified)
Jun 17, 2022
B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)
Recruiting
- B-Cell Non Hodgkin Lymphoma
- B-Cell Acute Lymphoblastic Leukemia
- anti-CD19 CAR T-cells
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023
Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)
Completed
- Recurrent Neuroendocrine Tumor
- Metastatic Neuroendocrine Tumor
-
Cleveland, OhioCleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022
Type 1 Diabetes Trial in Salt Lake City (FAMS-T1D, Digital resources for diabetes)
Recruiting
- Type 1 Diabetes
- FAMS-T1D
- Digital resources for diabetes
-
Salt Lake City, UtahUniversity of Utah
May 9, 2023
Type 1 Diabetes Trial in Salt Lake City (FAMS-T1D, Digital resources for diabetes)
Recruiting
- Type 1 Diabetes
- FAMS-T1D
- Digital resources for diabetes
-
Salt Lake City, UtahUniversity of Utah
Apr 7, 2023
Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)
Recruiting
- Multiple Myeloma
- ATAC-seq and ChIP-seq
-
Roma, Italy
- +1 more
May 4, 2023
Patients With Metastatic Bone Tumors (METABONE)
Active, not recruiting
- Metastatic Bone Tumor
- chemotherapy, surgery, radiotherapy, interventional radiology.
-
Bordeaux, FranceInstitut Bergonié, Comprehensive Cancer Center
Mar 4, 2022
Advanced MR Imaging in Sarcoma Patients
Completed
- Sarcoma
-
Rochester, MinnesotaMayo Clinic
Feb 11, 2022
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients
Not yet recruiting
- Possibility of Using microRNA30a as a Prognostic Marker in Philadelphia Positive Leukemic Patients by Measure Level of microRNA30a in Blood Sample
- (no location specified)
Nov 4, 2021
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
-
Los Angeles, California
- +9 more
Jun 27, 2023
Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)
Recruiting
- Metastatic Soft-tissue Sarcoma
- Cabozantinib
- +2 more
-
Stanford, California
- +3 more
Jan 10, 2023
Prognostic Study of HPV Virus Integration in Women With HSIL
Recruiting
- HPV Infection
- +2 more
- Follow up
-
Fuzhou, Fujian, China
- +12 more
Feb 16, 2023
Cannabis Use Disorder Trial in Paris (TIMCA, Treatment as Usual)
Recruiting
- Cannabis Use Disorder
- TIMCA
- Treatment as Usual
-
Paris, FranceGHU Paris Psychiatrie & Neurosciences
Mar 1, 2023
Developmental Delay Trial in Aberdeen (Fine and gross motor treatment only, Reflex integration + fine and gross motor treatment)
Active, not recruiting
- Developmental Delay
- Fine and gross motor treatment only
- Reflex integration + fine and gross motor treatment
-
Aberdeen, WashingtonAberdeen School District
Apr 10, 2023